podophyllotoxin has been researched along with Cancer of Prostate in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| But, PP; Hon, PM; Jiang, RW; Li, LL; Li, SL; Shaw, PC; Xu, HX; Ye, WC; Zhou, JR; Zhou, Y | 1 |
| Akunuri, R; Bhargava, SK; Bonam, SR; Kamal, A; Kumar, HMS; Naidu, VGM; Nayak, VL; Reddy, TS; Reddy, VG; Srihari, P | 1 |
| Chen, X; Lei, D; Li, D; Li, M; Lin, H; Lin, K; Wang, G; Zheng, Q; Zhu, X | 1 |
| Feng, J; Herman, HY; Jiang, RW; Li, J; Luo, C | 1 |
| Ahn, S; Barrett, CM; Dalton, JT; Duke, CB; Hwang, DJ; Miller, DD; Yang, J | 1 |
| Ahn, SC; Chatterjee, B; Cho, HJ; Kim, KY; Kim, SH; Kim, SY; Mirkheshti, N; Park, YM; Song, CS; Yu, HS; Yu, SN | 1 |
| Loprinzi, CL; Trump, DL | 1 |
| Fujita, K; Murayama, T; Sayama, T | 1 |
| Beckmann, C; Flury, R; Frei, P; Holdener, E; Jungi, WF; Senn, HJ | 1 |
| Caramia, G; Messana, V; Pavone-Macaluso, M; Rizzo, FP | 1 |
| Birch, R; Einhorn, LH; Greco, FA; Troner, M; Walther, PJ; Williams, SD | 1 |
| Ishibe, T; Moriyama, N; Nagafuji, T; Ohsumi, Y; Usui, T | 1 |
| Suzuki, K | 1 |
| Aota, Y; Kinjo, T; Mitsuya, H; Murase, T; Shimoji, T | 1 |
| Messmer, B | 1 |
2 trial(s) available for podophyllotoxin and Cancer of Prostate
| Article | Year |
|---|---|
Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Drug Evaluation; Humans; Infusions, Parenteral; Leiomyosarcoma; Male; Mitosis; Neoplasm Metastasis; Podophyllotoxin; Prostatic Neoplasms; Teniposide; Teratoma; Testicular Neoplasms; Therapeutic Irrigation; Urinary Bladder Neoplasms | 1975 |
Phase II study of etoposide for carcinoma of the prostate.
Topics: Blood Cell Count; Clinical Trials as Topic; Drug Evaluation; Etoposide; Hematologic Diseases; Humans; Male; Podophyllotoxin; Prostatic Neoplasms | 1986 |
14 other study(ies) available for podophyllotoxin and Cancer of Prostate
| Article | Year |
|---|---|
Lignans from Dysosma versipellis with inhibitory effects on prostate cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Berberidaceae; Drug Screening Assays, Antitumor; Humans; Lignans; Male; Molecular Structure; Plant Roots; Plants, Medicinal; Podophyllotoxin; Prostatic Neoplasms; Rhizome; Tumor Cells, Cultured | 2007 |
4β-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Humans; Male; Membrane Potential, Mitochondrial; Molecular Docking Simulation; Molecular Structure; Podophyllotoxin; Prostatic Neoplasms; Reactive Oxygen Species; Structure-Activity Relationship; Topoisomerase II Inhibitors; Triazoles; Tumor Cells, Cultured | 2018 |
Picropodophyllin Inhibits the Proliferation of Human Prostate Cancer DU145 and LNCaP Cells via ROS Production and PI3K/AKT Pathway Inhibition.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Male; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Podophyllotoxin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2022 |
Absolute configuration of podophyllotoxone and its inhibitory activity against human prostate cancer cells.
Topics: Antineoplastic Agents; Berberidaceae; Cell Line, Tumor; Dose-Response Relationship, Drug; G2 Phase; Humans; Hydrogen Bonding; Male; Molecular Conformation; Molecular Docking Simulation; Phytotherapy; Plant Extracts; Plant Roots; Podophyllotoxin; Polymerization; Prostatic Neoplasms; Tubulin; Tubulin Modulators | 2015 |
A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Binding Sites; Binding, Competitive; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Inhibitory Concentration 50; Male; Maximum Tolerated Dose; Mice; Mice, Inbred ICR; Mice, Nude; Microtubules; Molecular Structure; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Podophyllotoxin; Prostatic Neoplasms; Survival Rate; Tubulin; Tubulin Modulators; Vinblastine; Xenograft Model Antitumor Assays | 2011 |
Interplay of reactive oxygen species, intracellular Ca2+ and mitochondrial homeostasis in the apoptosis of prostate cancer cells by deoxypodophyllotoxin.
Topics: Apoptosis; bcl-2-Associated X Protein; Calcium; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Egtazic Acid; Enzyme Activation; G2 Phase Cell Cycle Checkpoints; Homeostasis; Humans; Intracellular Space; M Phase Cell Cycle Checkpoints; Male; Membrane Potential, Mitochondrial; Mitochondria; Models, Biological; Podophyllotoxin; Prostatic Neoplasms; Protein Transport; Reactive Oxygen Species | 2013 |
Phase II trial of etoposide in advanced prostate cancer.
Topics: Aged; Bone Marrow Diseases; Drug Evaluation; Etoposide; Humans; Infusions, Parenteral; Male; Middle Aged; Podophyllotoxin; Prostatic Neoplasms | 1984 |
[Effect of etoposide for pulmonary metastases from urogenital tract cancer].
Topics: Adenocarcinoma; Administration, Oral; Aged; Carcinoma, Transitional Cell; Etoposide; Humans; Infusions, Parenteral; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1984 |
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors].
Topics: Adenocarcinoma; Bronchial Neoplasms; Carcinoma; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Remission, Spontaneous | 1975 |
[Study of anti-cancer chemotherapy of prostatic carcinoma. I. Comparative study of ifosfamide and VIP against a hormone-independent human prostatic carcinoma cell line].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cells, Cultured; Cisplatin; Humans; Ifosfamide; Male; Podophyllotoxin; Prostatic Neoplasms | 1987 |
[Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
Topics: Adult; Aged; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1986 |
[Effect of etoposide for urogenital tumors].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pancreatic Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Rhabdomyosarcoma; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1985 |
[Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
Topics: Administration, Oral; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Kidney Neoplasms; Male; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urogenital Neoplasms | 1985 |
[Plasma iron turnover before and following cytostatic therapy and its signifiance as indicator of tumor activity].
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Follow-Up Studies; Humans; Iron; Iron Isotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Prostatic Neoplasms; Rectal Neoplasms; Thyroid Neoplasms; Time Factors; Urinary Bladder Neoplasms | 1968 |